Host–virus interactions in hepatitis B and hepatitis C infection Sachiyo YoshioTatsuya Kanto Review 19 February 2016 Pages: 409 - 420
Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience Hitoshi MaruyamaTadashi SekimotoOsamu Yokosuka Review 22 December 2015 Pages: 421 - 433
Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease Shapur IkhtaireMohammad Sharif ShajibWaliul Islam Khan Review 20 February 2016 Pages: 434 - 446
Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras Yasuo KawaguchiTakao HinoiHideki Ohdan Original Article—Alimentary Tract 11 September 2015 Pages: 447 - 457
Esophageal motility after peroral endoscopic myotomy for achalasia Yue HuMeng LiHaibiao Bao Original Article—Alimentary Tract 25 October 2015 Pages: 458 - 464
Factors affecting recurrence and prognosis after R0 resection for colorectal cancer with peritoneal metastasis Harunobu SatoKoutaro MaedaHiroshi Takahashi Original Article—Alimentary Tract 16 September 2015 Pages: 465 - 472
Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features Fukiko Kawai-KitahataYasuhiro AsahinaMamoru Watanabe Original Article—Liver, Pancreas, and Biliary Tract 09 November 2015 Pages: 473 - 486
Hepatitis B surface antigen seroclearance during nucleoside analogue therapy: surface antigen kinetics, outcomes, and durability Wai-Kay SetoKa-Shing CheungMan-Fung Yuen Original Article—Liver, Pancreas, and Biliary Tract 07 October 2015 Pages: 487 - 495
Appropriate use of virtual touch quantification and FibroScan® M and XL probes according to the skin capsular distance Erina KumagaiKeiko KorenagaSumio Watanabe Original Article—Liver, Pancreas, and Biliary Tract 13 October 2015 Pages: 496 - 505
Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer? Takeshi YamadaYoshiyuki YamamotoIchisnosuke Hyodo Letter to the Editor 18 February 2016 Pages: 506 - 507
Reply to the letter by Takeshi Yamada et al. concerning “Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?” Jun ZhouZhi PengLin Shen Letter to the Editor 20 February 2016 Pages: 508 - 508
Erratum to: Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy Jun ZhouZhi PengLin Shen Erratum 08 March 2016 Pages: 509 - 510